ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Demographics"

  • Abstract Number: 0605 • ACR Convergence 2020

    How Did SARS-CoV2/COVID-19 Pandemic Affected Rheumatology Practice in Latin America? A Regional Survey from PANLAR

    Daniel Fernández-Ávila1, Julián Barahona-Correa1, Diana Romero-Alvernia1, Sergio Kowalski2, Ana María Sapag Durán3, Antonio Cachafeiro Vilar4, Belia Lucía Meléndez Muñoz5, Carlos Santiago Pastelín6, Daniel Palleiro Rivero7, Dina María Arrieta8, Guillermo Pons-Estel9, Jossiell Then Báez10, Manuel Ugarte-Gil11, Mario Cardiel12, Nelly Colman13, Nilmo Chávez Pérez14, Paula Burgos15, Rubén Montufar16, Sayonara Sandino17, Yurilis Fuentes-Silva18 and Enrique Soriano19, 1Pontificia Universidad Javeriana - Hospital Universitario San Ignacio, Bogota, Colombia, 2Unidad de Investigación PANLAR. Universidade Federal do Paraná, Paraná, Brazil, 3Hospital Universitario Japonés, Santa Cruz, Bolivia, 4Pacífica Salud - Hospital Punta Pacífica,, Ciudad de Panamá, Panama, 5Hospital de la Policía Nacional N1 Quito, Quito, Ecuador, 6Instituto Hondureño de la Seguridad Social, Tegucigalpa, Honduras, 7Instituto Nacional de Reumatología del Uruguay - Universidad de la República, Montevideo, Uruguay, 8Hospital México, San José de Costa Rica, Costa Rica, 9Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, 10Hospital Metropolitano de Santiago (HOMS), Santiago, Dominican Republic, 11Servicio de Reumatología. Hospital Nacional Guillermo Almenara Irigoyen and Universidad Científica del Sur, Lima, Peru, 12Centro de Investigación Clínica de Morelia, Morelia, Mexico, 13Hospital de Clínicas - Universidad Nacional de Asunción, Asunción, Paraguay, 14Instituto Guatemalteco de Seguridad Social, Ciudad de Guatemala, Guatemala, 15Universidad Católica de Chile, Santiago de Chile, Chile, 16Consultorio de Especialidades del Instituto Salvadoreño del Seguro Social, San Salvador, El Salvador, 17Policlínica Nicaragüense, Managua, Nicaragua, 18Centro Clínico Universitario de Oriente - Universidad de Oriente, Ciudad Bolivar, Venezuela, 19Department of Public Health, Instituto Universitario, Escuela de Medicina Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Capital Federal, Buenos Aires, Argentina

    Background/Purpose: Since December 2019, a novel coronavirus (SARS-CoV-2) pandemic was declared. Social isolation became a mainstay for the prevention of disease expansion. Outpatient follow-up of…
  • Abstract Number: 0831 • ACR Convergence 2020

    Sociodemographic, Disease, and Medication Profile of RA Patients Under 65 Years Compared with 65 Years or Older at Registry Enrollment: Real World Results from a Rheumatoid Arthritis Cohort

    Mohammad Movahedi1, Angela Cesta2, Xiuying Li3 and Claire Bombardier4, 1Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 2Toronto General Hospital Research Institute, Toronto, ON, Canada, 3Toronto General Hospital Research Institute, Toronto, Canada, 4Institute for Work and Health, Toronto, ON, Canada

    Background/Purpose: Age is an important factor that can affect disease course, physical function and treat to target strategy for patients with rheumatoid arthritis (RA). We…
  • Abstract Number: 1140 • ACR Convergence 2020

    How Did SARS-CoV2/COVID-19 Pandemic Affected Patients with Rheumatic Diseases in Latin America? A Regional Survey from PANLAR

    Daniel Fernández-Ávila1, Julián Barahona-Correa1, Diana Romero-Alvernia1, Sergio Kowalski2, Ana María Sapag Durán3, Antonio Cachafeiro Vilar4, Belia Lucía Meléndez Muñoz5, Carlos Santiago Pastelín6, Claudia Ramírez7, Daniel Palleiro Rivero8, Diego Alejandro Jaimes9, Dina María Arrieta10, Guillermo Pons-Estel11, Jossiell Then Báez12, Manuel Ugarte-Gil13, Mario Cardiel14, Nelly Colman15, Nilmo Chávez Pérez16, Paula Burgos17, Rubén Montufar18, Sayonara Sandino19, Yurilis Fuentes-Silva20 and Enrique Soriano21, 1Pontificia Universidad Javeriana - Hospital Universitario San Ignacio, Bogota, Colombia, 2Unidad de Investigación PANLAR. Universidade Federal do Paraná, Paraná, Brazil, 3Hospital Universitario Japonés, Santa Cruz, Bolivia, 4Pacífica Salud - Hospital Punta Pacífica,, Ciudad de Panamá, Panama, 5Hospital de la Policía Nacional N1 Quito, Quito, Ecuador, 6Instituto Hondureño de la Seguridad Social, Tegucigalpa, Honduras, 7Organización Keralty, Bogota, 8Instituto Nacional de Reumatología del Uruguay - Universidad de la República, Montevideo, Uruguay, 9Clínicos IPS- Universidad de la Sabana, Bogotá D.C., Colombia, 10Hospital México, San José de Costa Rica, Costa Rica, 11Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, 12Hospital Metropolitano de Santiago (HOMS), Santiago, Dominican Republic, 13Servicio de Reumatología. Hospital Nacional Guillermo Almenara Irigoyen and Universidad Científica del Sur, Lima, Peru, 14Centro de Investigación Clínica de Morelia, Morelia, Mexico, 15Hospital de Clínicas - Universidad Nacional de Asunción, Asunción, Paraguay, 16Instituto Guatemalteco de Seguridad Social, Ciudad de Guatemala, Guatemala, 17Universidad Católica de Chile, Santiago de Chile, Chile, 18Consultorio de Especialidades del Instituto Salvadoreño del Seguro Social, San Salvador, El Salvador, 19Policlínica Nicaragüense, Managua, Nicaragua, 20Centro Clínico Universitario de Oriente - Universidad de Oriente, Ciudad Bolivar, Venezuela, 21Department of Public Health, Instituto Universitario, Escuela de Medicina Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Capital Federal, Buenos Aires, Argentina

    Background/Purpose: Social isolation during SARS-CoV-2/COVID-19 pandemic has undermined follow-up of patients with rheumatic diseases. These patients face a critical dilemma between the risk of exposure…
  • Abstract Number: 1164 • ACR Convergence 2020

    Frequency of Genetic Diagnosis in an Autoinflammatory Disease Natural History Protocol Cohort of Patients

    Katelin R. Honer1, Kim Johnson1, Gema Souto Adeva1, Gina Montealegre Sanchez2, Jenna Wade3, Jacob Mitchell1, Katherine Townsend3, Adriana de Jesus4 and Raphaela Goldbach-Mansky5, 1Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Bethesda, MD, 2Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Rockville, MD, 3Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Bethesda, 4Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Silver Spring, MD, 5Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Potomac, MD

    Background/Purpose: Monogenic autoinflammatory diseases (AID) are caused by innate immune dysregulation resulting in systemic inflammation and variable organ-specific clinical manifestations. The Translational Autoinflammatory Disease Section…
  • Abstract Number: 1388 • ACR Convergence 2020

    A Systematic Assessment of Demographics, Clinical and Serological Features Associated with Colonic Hypomotility in Systemic Sclerosis

    Jenice Cheah1, Jamie Perin2, Elizabeth Volkmann3, Laura Hummers4, Fredrick Wigley5 and Zsuzsanna McMahan6, 1JHUSOM, Baltimore, 2JHUSPH, Baltimore, 3University of California, Los Angeles, Los Angeles, CA, 4Johns Hopkins Univerisity, Ellicott City, MD, 5Johns Hopkins University School of Medicine, Baltimore, MD, 6Johns Hopkins University, Baltimore

    Background/Purpose: Colonic dysmotility affects up to 50% of patients with systemic sclerosis (SSc). While some patients have mild colonic disease, others experience severe complications, such…
  • Abstract Number: 0004 • ACR Convergence 2020

    The Impact of the COVID-19 Pandemic on Patients with Chronic Rheumatic Diseases: A Study in 15 Arab Countries

    Nelly Ziade1, Lina El Kibbi2, Ihsane Hmamouchi3, Nizar Abdulateef4, Hussein Halabi5, Wafa Hamdi6, Fatemah Abutiban7, Manal el Rakawi8, Mervat Eissa9 and Basel Masri10, 1Saint-Joseph University, Beirut, Lebanon, Beirut, Lebanon, 2Specialized Medical Center, Riyadh, Saudi Arabia, Riyadh, Saudi Arabia, 3Temara Hospital, Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco, Rabat, Morocco, 4Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Iraq, Baghdad, Iraq, 5King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, Jeddah, Saudi Arabia, 6Department of Rheumatology, Kassab Institute of orthopedics, UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia, Tunis, Tunisia, 7Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah hospital, State of Kuwait, Jahra, Kuwait, 8Departement of Rheumatology, Douera Hospital, Faculty of Medicine, Saad Dahlab, Blida, Algeria, Blida, Algeria, 9Rheumatology Department, Cairo University, Cairo, Egypt, Cairo, Egypt, 10Jordan Hospital, Amman, Jordan, Amman, Jordan

    Background/Purpose: To evaluate the impact of the Coronavirus Disease 2019 pandemic (COVID-19) on the access to rheumatology care for patients with chronic rheumatic diseases in…
  • Abstract Number: 1419 • ACR Convergence 2020

    Clinical Disease Might Be Divided into Two Phenotypes in ANCA Associated Vasculitis; Results of a Cluster Analysis

    Elif Ediboglu1, Onay Gercik2, Emre Bilgin3, Dilek Solmaz4, Irfan Ocal5, Arzu Saglam6, Zeki Soypacacı2, Haluk Cinaklı5, Sedat Kiraz3, Ömer Karadağ7 and Servet Akar2, 1Izmir Katip Celebi University, Izmir, Izmir, Turkey, 2Izmir Katip Celebi University, Izmir, Turkey, 3Hacettepe University, Ankara, Turkey, 4Izmir Katip Celebi University, Department of Internal Medicine, Division of Rheumatology, Izmir, TURKEY, Izmir, Turkey, 5Izmir Katip Celebi University, Izmir, 6Hacettepe University, Ankara, 7Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara,, Ankara, Turkey

    Background/Purpose: One of the controversial matters in ANCA associated vasculitis is the definition of disease based on clinical characteristics since there is a remarkable overlap…
  • Abstract Number: 0018 • ACR Convergence 2020

    PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City

    Gregory Vitone1, Marianna Frey2, Candace Feldman3, Lindsay Lally2, Anne Bass4, Jane Salmon2, Mary Crow2, Michael Lockshin5, Vivian Bykerk2, Medha Barbhaiya5 and Lisa Mandl2, 1Hospital for Special Surgery, New York, 2Hospital for Special Surgery, New York, NY, 3Brigham and Women's Hospital, Boston, MA, 4Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 5Hospital for Special Surgery, Barbara Volcker Center for Women and Rheumatic Diseases, New York, NY

    Background/Purpose: Little is known about the general health and wellbeing of patients with systemic rheumatic diseases (SRD) during the COVID pandemic.  We sought to compare…
  • Abstract Number: 1569 • ACR Convergence 2020

    Immune Related Adverse Events Related to Check Point Inhibitors Among Outpatients in an Academic Center

    Bushra Akram1, Aleena Itani1, Mohammad Razaq2, Samera Vaseer1, Sara Vesely1 and Pawan Acharya1, 1University of Oklahoma Health Sciences Center, Oklahoma City, 2University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Immune check point inhibitors (ICIs) allow the body to recognize tumor cells as non-self, resulting in immune-cell mediated tumor cell destruction. These therapies have the…
  • Abstract Number: 0043 • ACR Convergence 2020

    Geographical Disparity in Rheumatoid Arthritis Disease Burden Independent of Race/Ethnicity

    Gail Kerr1, Christopher Swearingen2, Manuela Pedra-Nobre3, Dianne Wollaston4, Sawsan Najmey5, Cynthia Lawrence-Elliott6, Theresa Lawrence Ford6, Sharon Dowell7, Heather North8, Robin Dore9, Soha Dolatabadi10, Thaila Ramanujam11, Anne Winkler12, Stacy Kennedy13, Ilona Jileaeva14, Amina Richardson15, Jeffrey Kaine16 and Grace Wright17, 1Washington DC VA Medical Center, Washington, DC, 2New York University, New York, NY, 3North Jersey Rheumatology Center, Westfield, NJ, 4Memorial Advanced Rheumatology, Inc, HOUSTON, TX, 5Midstate Rheumatology Center, Freehold, NJ, 6North Georgia Rheumatology Group, Lawrenceville, GA, 7Howard University, Washington, DC, 8Pardee UNC Rheumatology, Hendersonville, NC, 9Private practice, Tustin, CA, 10Soha Dolatabadi, MD, Los Angeles, CA, 11Thaila Ramanujanm. M.D Inc, Santa Cruz, CA, 12Cox Medical Center, Springfield, MO, 13Rowan Diagnostic Clinic, Concord, NC, 14Howard University Hospital, Washington, DC, 15Howard University College of Medicine, Washington, DC, 16Sarasota Arthritis Center, Sarasota, FL, 17Association of Women in Rheumatology, New York, NY

    Background/Purpose: In the US, health care systems vary, as does cost sharing and access to various RA therapies. However, the burden of RA – a…
  • Abstract Number: 1604 • ACR Convergence 2020

    The Impact of the COVID-19 Pandemic on Rheumatology Practice: A Study in 15 Arab Countries

    Nelly Ziade1, Ihsane Hmamouchi2, Lina El Kibbi3, Nizar Abdulateef4, Hussein Halabi5, Fatemah Abutiban6, Wafa Hamdi7, Manal el Rakawi8, Mervat Eissa9 and Basel Masri10, 1Saint-Joseph University, Beirut, Lebanon, Beirut, Lebanon, 2Temara Hospital, Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco, Rabat, Morocco, 3Specialized Medical Center, Riyadh, Saudi Arabia, Riyadh, Saudi Arabia, 4Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Iraq, Baghdad, Iraq, 5King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, Jeddah, Saudi Arabia, 6Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah hospital, State of Kuwait, Jahra, Kuwait, 7Department of Rheumatology, Kassab Institute of orthopedics, UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia, Tunis, Tunisia, 8Departement of Rheumatology, Douera Hospital, Faculty of Medicine, Saad Dahlab, Blida, Algeria, Blida, Algeria, 9Rheumatology Department, Cairo University, Cairo, Egypt, Cairo, Egypt, 10Jordan Hospital, Amman, Jordan, Amman, Jordan

    Background/Purpose: To date, information about the impact of the Coronavirus Disease (COVID-19) pandemic on rheumatology practice and on rheumatologists is limited.The primary objective of the…
  • Abstract Number: 0044 • ACR Convergence 2020

    Characterization of Racial Disparities in Rheumatoid Arthritis Treatment Choice and Location of Care

    Elston He1, Eli Cornblath2, Pratyusha Yalamanchi3, Alexis Ogdie2, Joshua Baker2 and Michael George2, 1Synovium, Inc., Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Michigan Medicine, Ann Arbor, MI

    Background/Purpose: Racial disparities in access to care and treatment regimens exist but remain poorly characterized in the rheumatoid arthritis (RA) patient population. Previous studies using…
  • Abstract Number: 1653 • ACR Convergence 2020

    Bilateral vs Unilateral Total Knee Arthroplasty: Racial Variation in Utilization and In-Hospital Major Complication Rates

    Bella Mehta1, Kaylee Ho2, Jennifer Bido3, Stavros Memtsoudis3, Michael Parks4, Susan Goodman1, Linda Russell5 and Said Ibrahim6, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Weill Cornell Medicine, New York, 3Hospital for Special Surgery, New York, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, 5Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 6Weill Cornell Medicine, Cleveland, OH

    Background/Purpose: Compared to White Patients, African Americans (AAs) are reported to have lower utilization and higher complication rates outcomes in Unilateral Total knee arthroplasty (UTKA).…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology